SI2683381T1 - Pripravek, ki obsega aktivno snov v obliki derivata fenilaminopirimidina - Google Patents

Pripravek, ki obsega aktivno snov v obliki derivata fenilaminopirimidina

Info

Publication number
SI2683381T1
SI2683381T1 SI201130592T SI201130592T SI2683381T1 SI 2683381 T1 SI2683381 T1 SI 2683381T1 SI 201130592 T SI201130592 T SI 201130592T SI 201130592 T SI201130592 T SI 201130592T SI 2683381 T1 SI2683381 T1 SI 2683381T1
Authority
SI
Slovenia
Prior art keywords
formulation
active agent
phenylaminopyrimidine derivative
phenylaminopyrimidine
derivative
Prior art date
Application number
SI201130592T
Other languages
English (en)
Slovenian (sl)
Inventor
Durga Maheswari Parvataneni
Siddhartha Yedluri
Venkata Satyanarayana Appadwedula
Kali Satya Bhujanga Rao Adibhatla
Venkaiah Chowdary Nannapaneni
Original Assignee
Natco Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43923331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2683381(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Natco Pharma Limited filed Critical Natco Pharma Limited
Publication of SI2683381T1 publication Critical patent/SI2683381T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SI201130592T 2011-03-07 2011-08-10 Pripravek, ki obsega aktivno snov v obliki derivata fenilaminopirimidina SI2683381T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1103860.1A GB2488788B (en) 2011-03-07 2011-03-07 Oral formulation of phenylaminopyrymidine compound with enhanced bioavailability and pharmacological response
EP11764851.9A EP2683381B1 (en) 2011-03-07 2011-08-10 Formulation comprising phenylaminopyrimidine derivative as active agent
PCT/IB2011/001842 WO2012120328A1 (en) 2011-03-07 2011-08-10 Formulation comprising phenylaminopyrimidine derivative as active agent

Publications (1)

Publication Number Publication Date
SI2683381T1 true SI2683381T1 (sl) 2016-01-29

Family

ID=43923331

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201130592T SI2683381T1 (sl) 2011-03-07 2011-08-10 Pripravek, ki obsega aktivno snov v obliki derivata fenilaminopirimidina

Country Status (33)

Country Link
US (1) US9895367B2 (OSRAM)
EP (1) EP2683381B1 (OSRAM)
JP (1) JP5788534B2 (OSRAM)
KR (1) KR101767296B1 (OSRAM)
CN (1) CN103561742B (OSRAM)
AP (1) AP4076A (OSRAM)
AU (1) AU2011361921B2 (OSRAM)
BR (1) BR112013022930A2 (OSRAM)
CA (1) CA2829015C (OSRAM)
CO (1) CO6811851A2 (OSRAM)
CY (1) CY1116968T1 (OSRAM)
DK (1) DK2683381T3 (OSRAM)
EA (1) EA024610B1 (OSRAM)
ES (1) ES2554927T3 (OSRAM)
GB (1) GB2488788B (OSRAM)
GE (1) GEP20156410B (OSRAM)
HR (1) HRP20151382T1 (OSRAM)
HU (1) HUE025562T2 (OSRAM)
IL (1) IL228218A (OSRAM)
MA (1) MA35088B1 (OSRAM)
MX (1) MX339130B (OSRAM)
MY (1) MY158693A (OSRAM)
NZ (1) NZ614903A (OSRAM)
PH (1) PH12013501844A1 (OSRAM)
PL (1) PL2683381T3 (OSRAM)
PT (1) PT2683381E (OSRAM)
RS (1) RS54420B1 (OSRAM)
SG (1) SG193349A1 (OSRAM)
SI (1) SI2683381T1 (OSRAM)
SM (1) SMT201500235B (OSRAM)
UA (1) UA111074C2 (OSRAM)
WO (1) WO2012120328A1 (OSRAM)
ZA (1) ZA201306643B (OSRAM)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1254573A1 (zh) * 2015-12-18 2019-07-19 Natco Pharma Limited 包含苯基氨基嘧啶衍生物的药物组合物
WO2017115316A1 (en) * 2015-12-29 2017-07-06 Noivita S.R.L.S. Lipophilic formulations
CN107184549B (zh) * 2017-04-11 2020-11-20 江苏大学 一种尼达尼布自微乳制剂和其制成的软胶囊及制备方法
CN107564610A (zh) * 2017-10-20 2018-01-09 浙江中大元通特种电缆有限公司 一种陶瓷化硅橡胶绝缘护套不锈钢连锁铠装防火电缆
SG11202008226YA (en) 2018-03-14 2020-09-29 Kandy Therapeutics Ltd Novel pharmaceutical formulation comprising dual nk-1/nk-3 receptor antagonists
CN113473974A (zh) * 2019-01-25 2021-10-01 深圳市药欣生物科技有限公司 药物组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
NZ502569A (en) * 1997-07-29 2002-05-31 Upjohn Co Self-emulsifying formulation for lipophilic compounds comprising a mixture of diglyceride and monoglyceride in a ratio of 9:1 to 6:4
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US7232825B2 (en) * 2003-05-02 2007-06-19 Guoqing P Chen Phenylaminopyrimidine derivatives and methods of use
EP1498143A1 (en) 2003-07-18 2005-01-19 Aventis Pharma S.A. Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
BRPI0515081B8 (pt) 2004-09-09 2021-05-25 Natco Pharma Ltd composto, processo para a preparação de um sal de guanidino trifluormetilaroil amida, processo para a preparação de um fenil amino pirido pirimidina, composições farmacêuticas e processos para preparar (3,5-bis trifluormetil)-n-[4-metil-3-(4-piridin-3-il-pirimidin-2-ilamino)-fenil]-benzamida
EP2076507A2 (en) * 2006-10-26 2009-07-08 Sicor, Inc. Imatinib base, and imatinib mesylate and processes for preparation thereof
EP1920767A1 (en) * 2006-11-09 2008-05-14 Abbott GmbH & Co. KG Melt-processed imatinib dosage form
WO2008134731A1 (en) * 2007-04-30 2008-11-06 Intezyne Technologies, Inc. Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents
MY175373A (en) 2008-03-04 2020-06-23 Natco Pharma Ltd Crystal form of phenylamino pyrimidine derivatives
US8067422B2 (en) * 2008-03-04 2011-11-29 Natco Pharma Limited Crystal form of phenylamino pyrimidine derivatives
WO2010068311A1 (en) * 2008-05-23 2010-06-17 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein inhibitor

Also Published As

Publication number Publication date
AU2011361921A2 (en) 2014-10-30
RS54420B1 (sr) 2016-04-28
ES2554927T3 (es) 2015-12-28
NZ614903A (en) 2014-08-29
CN103561742A (zh) 2014-02-05
KR20140016926A (ko) 2014-02-10
CN103561742B (zh) 2016-04-27
PH12013501844A1 (en) 2015-10-23
DK2683381T3 (en) 2015-12-21
HRP20151382T1 (hr) 2016-02-12
WO2012120328A1 (en) 2012-09-13
AU2011361921B2 (en) 2016-06-09
AP2013007128A0 (en) 2013-09-30
MX339130B (es) 2016-05-13
HUE025562T2 (en) 2016-03-29
UA111074C2 (uk) 2016-03-25
EA201391280A1 (ru) 2014-02-28
GEP20156410B (en) 2015-12-10
SG193349A1 (en) 2013-10-30
EP2683381B1 (en) 2015-09-16
MX2013010160A (es) 2013-12-06
GB201103860D0 (en) 2011-04-20
EP2683381A1 (en) 2014-01-15
US20130338180A1 (en) 2013-12-19
AP4076A (en) 2017-03-23
SMT201500235B (it) 2015-10-30
JP5788534B2 (ja) 2015-09-30
CO6811851A2 (es) 2013-12-16
AU2011361921A1 (en) 2013-09-26
PT2683381E (pt) 2015-11-02
CA2829015A1 (en) 2012-09-13
CA2829015C (en) 2018-01-02
GB2488788B (en) 2013-07-10
ZA201306643B (en) 2014-11-26
KR101767296B1 (ko) 2017-08-10
IL228218A (en) 2016-06-30
EA024610B1 (ru) 2016-10-31
MY158693A (en) 2016-11-15
PL2683381T3 (pl) 2016-06-30
MA35088B1 (fr) 2014-05-02
CY1116968T1 (el) 2017-04-05
BR112013022930A2 (pt) 2016-12-06
GB2488788A (en) 2012-09-12
JP2014507463A (ja) 2014-03-27
US9895367B2 (en) 2018-02-20

Similar Documents

Publication Publication Date Title
GB201111438D0 (en) Formulation
ZA201309221B (en) Formulation
GB2525835B (en) Pharmaceutical agent
ZA201306000B (en) Stable formulation
PL2836580T3 (pl) Mikrofibrylarna celuloza jako substancja czynna zdolna do odrywania brudu
PT2739276T (pt) Composição antisséptica
SMT201500235B (it) Formulazione comprendente derivato di fenilamminopirimidina come agente attivo
PL2701506T3 (pl) Składnik formulacji
ZA201402456B (en) Formulation
ZA201305986B (en) Improved insecticide formulations
SI2794550T1 (sl) Oftalmološka formulacija
GB201121377D0 (en) Formulation component
GB201107039D0 (en) Formulation component
ZA201308192B (en) A topical formulation comprising a corticosteroid as active ingredient
GB2496656B (en) Film-Forming Formulation
HUE037814T2 (hu) Formulációs összetevõ
GB201106958D0 (en) Formulation
GB201104284D0 (en) Formulation
AU2011902822A0 (en) Disinfecting formulation
GB201110030D0 (en) Topical formulation
GB201110027D0 (en) Topical formulation
AU2011905445A0 (en) Formulation
AU2011904841A0 (en) Formulation
AU2011905442A0 (en) Formulation
GB201108234D0 (en) Pharmaceutical agent